Optimind Pharma (XCNQ:OMND) Short-Term Capital Lease Obligation : C$0.00 Mil (As of Nov. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma Short-Term Capital Lease Obligation?

Optimind Pharma's Short-Term Capital Lease Obligation for the quarter that ended in Nov. 2023 was C$0.00 Mil.

Optimind Pharma's quarterly Short-Term Capital Lease Obligation increased from May. 2023 (C$0.03 Mil) to Aug. 2023 (C$0.03 Mil) but then declined from Aug. 2023 (C$0.03 Mil) to Nov. 2023 (C$0.00 Mil).

Optimind Pharma's annual Short-Term Capital Lease Obligation increased from . 20 (C$0.00 Mil) to Feb. 2022 (C$0.02 Mil) and increased from Feb. 2022 (C$0.02 Mil) to Feb. 2023 (C$0.03 Mil).

Optimind Pharma Short-Term Capital Lease Obligation Historical Data

The historical data trend for Optimind Pharma's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma Short-Term Capital Lease Obligation Chart

Optimind Pharma Annual Data

Trend

Feb22

Feb23

Short-Term Capital Lease Obligation

0.02

0.03

Optimind Pharma Quarterly Data
	Jun21	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial			0.03	0.03	0.03	0.03	-

Optimind Pharma Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Optimind Pharma Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma (XCNQ:OMND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

3000 - 77 King Street West, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8

Website

https://www.optimindpharma.com

Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities.

Optimind Pharma (XCNQ:OMND) Headlines

No Headlines